The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
Identifieur interne : 000A90 ( PubMed/Corpus ); précédent : 000A89; suivant : 000A91The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
Auteurs : Gilles Fénelon ; Thierry Soulas ; Franck Zenasni ; Laurent Cleret De LangavantSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.
English descriptors
- KwdEn :
- Aged, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, National Institute of Mental Health (U.S.) (standards), National Institute of Neurological Disorders and Stroke (standards), Parkinson Disease (complications), Parkinson Disease (diagnosis), Psychotic Disorders (complications), Psychotic Disorders (diagnosis), Reference Values, United States.
- MESH :
- geographic : United States.
- complications : Parkinson Disease, Psychotic Disorders.
- diagnosis : Parkinson Disease, Psychotic Disorders.
- standards : National Institute of Mental Health (U.S.), National Institute of Neurological Disorders and Stroke.
- Aged, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Reference Values.
Abstract
New criteria for Parkinson's disease-associated psychosis (PDAP) were recently proposed by a NINDS-NIMH working group. We assessed 116 consecutive unselected outpatients with PD for the existence of psychotic symptoms during the previous month, using a structured questionnaire covering the whole spectrum of PDAP symptoms. Hallucinations occurred in 42% of the patients (visual: 16%; nonvisual: 35%), delusions in 4%, and minor symptoms in 45% (sense of presence, visual illusions, or passage hallucinations). The prevalence of PDAP was 43% when the usual definition was used (hallucinations and/or delusions) and 60% when the NINDS-NIHM criteria were used. Correlations between PDAP and patient characteristics varied with the definition of PDAP. These findings suggest that the epidemiology of PDAP should be re-evaluated with the new criteria. Minor symptoms and nonvisual hallucinations are an important part of the PDAP spectrum, which has commonly been restricted to visual hallucinations and delusions.
DOI: 10.1002/mds.22839
PubMed: 20437542
Links to Exploration step
pubmed:20437542Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.</title>
<author><name sortKey="Fenelon, Gilles" sort="Fenelon, Gilles" uniqKey="Fenelon G" first="Gilles" last="Fénelon">Gilles Fénelon</name>
<affiliation><nlm:affiliation>AP-HP, Department of Neurology, CHU Henri Mondor, Créteil, France. gilles.fenelon@hmn.aphp.fr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Soulas, Thierry" sort="Soulas, Thierry" uniqKey="Soulas T" first="Thierry" last="Soulas">Thierry Soulas</name>
</author>
<author><name sortKey="Zenasni, Franck" sort="Zenasni, Franck" uniqKey="Zenasni F" first="Franck" last="Zenasni">Franck Zenasni</name>
</author>
<author><name sortKey="Cleret De Langavant, Laurent" sort="Cleret De Langavant, Laurent" uniqKey="Cleret De Langavant L" first="Laurent" last="Cleret De Langavant">Laurent Cleret De Langavant</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20437542</idno>
<idno type="pmid">20437542</idno>
<idno type="doi">10.1002/mds.22839</idno>
<idno type="wicri:Area/PubMed/Corpus">000A90</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A90</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.</title>
<author><name sortKey="Fenelon, Gilles" sort="Fenelon, Gilles" uniqKey="Fenelon G" first="Gilles" last="Fénelon">Gilles Fénelon</name>
<affiliation><nlm:affiliation>AP-HP, Department of Neurology, CHU Henri Mondor, Créteil, France. gilles.fenelon@hmn.aphp.fr</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Soulas, Thierry" sort="Soulas, Thierry" uniqKey="Soulas T" first="Thierry" last="Soulas">Thierry Soulas</name>
</author>
<author><name sortKey="Zenasni, Franck" sort="Zenasni, Franck" uniqKey="Zenasni F" first="Franck" last="Zenasni">Franck Zenasni</name>
</author>
<author><name sortKey="Cleret De Langavant, Laurent" sort="Cleret De Langavant, Laurent" uniqKey="Cleret De Langavant L" first="Laurent" last="Cleret De Langavant">Laurent Cleret De Langavant</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>National Institute of Mental Health (U.S.) (standards)</term>
<term>National Institute of Neurological Disorders and Stroke (standards)</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Psychotic Disorders (complications)</term>
<term>Psychotic Disorders (diagnosis)</term>
<term>Reference Values</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>National Institute of Mental Health (U.S.)</term>
<term>National Institute of Neurological Disorders and Stroke</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Reference Values</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">New criteria for Parkinson's disease-associated psychosis (PDAP) were recently proposed by a NINDS-NIMH working group. We assessed 116 consecutive unselected outpatients with PD for the existence of psychotic symptoms during the previous month, using a structured questionnaire covering the whole spectrum of PDAP symptoms. Hallucinations occurred in 42% of the patients (visual: 16%; nonvisual: 35%), delusions in 4%, and minor symptoms in 45% (sense of presence, visual illusions, or passage hallucinations). The prevalence of PDAP was 43% when the usual definition was used (hallucinations and/or delusions) and 60% when the NINDS-NIHM criteria were used. Correlations between PDAP and patient characteristics varied with the definition of PDAP. These findings suggest that the epidemiology of PDAP should be re-evaluated with the new criteria. Minor symptoms and nonvisual hallucinations are an important part of the PDAP spectrum, which has commonly been restricted to visual hallucinations and delusions.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20437542</PMID>
<DateCreated><Year>2010</Year>
<Month>05</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>07</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>12</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>6</Issue>
<PubDate><Year>2010</Year>
<Month>Apr</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.</ArticleTitle>
<Pagination><MedlinePgn>763-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22839</ELocationID>
<Abstract><AbstractText>New criteria for Parkinson's disease-associated psychosis (PDAP) were recently proposed by a NINDS-NIMH working group. We assessed 116 consecutive unselected outpatients with PD for the existence of psychotic symptoms during the previous month, using a structured questionnaire covering the whole spectrum of PDAP symptoms. Hallucinations occurred in 42% of the patients (visual: 16%; nonvisual: 35%), delusions in 4%, and minor symptoms in 45% (sense of presence, visual illusions, or passage hallucinations). The prevalence of PDAP was 43% when the usual definition was used (hallucinations and/or delusions) and 60% when the NINDS-NIHM criteria were used. Correlations between PDAP and patient characteristics varied with the definition of PDAP. These findings suggest that the epidemiology of PDAP should be re-evaluated with the new criteria. Minor symptoms and nonvisual hallucinations are an important part of the PDAP spectrum, which has commonly been restricted to visual hallucinations and delusions.</AbstractText>
<CopyrightInformation>2010 Movement Disorder Society</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fénelon</LastName>
<ForeName>Gilles</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>AP-HP, Department of Neurology, CHU Henri Mondor, Créteil, France. gilles.fenelon@hmn.aphp.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Soulas</LastName>
<ForeName>Thierry</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zenasni</LastName>
<ForeName>Franck</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cleret de Langavant</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Brain. 2000 Apr;123 ( Pt 4):733-45</RefSource>
<PMID Version="1">10734005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</RefSource>
<PMID Version="1">2841426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2005 Feb;20(2):130-40</RefSource>
<PMID Version="1">15486924</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Neuropharmacol. 2005 Sep-Oct;28(5):215-9</RefSource>
<PMID Version="1">16239760</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2005 Nov;20(11):1439-48</RefSource>
<PMID Version="1">16028215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Behav Brain Sci. 2005 Dec;28(6):737-57; discussion 757-94</RefSource>
<PMID Version="1">16372931</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pract Neurol. 2008 Aug;8(4):238-41</RefSource>
<PMID Version="1">18644910</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Ther. 2006 Jan;28(1):1-12</RefSource>
<PMID Version="1">16490575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2007 Jun 15;22(8):1061-8</RefSource>
<PMID Version="1">17266092</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CNS Spectr. 2008 Mar;13(3 Suppl 4):18-25</RefSource>
<PMID Version="1">18323763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2008 Mar 15;23(4):484-500</RefSource>
<PMID Version="1">18175343</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):652-5</RefSource>
<PMID Version="1">17872984</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Neurol. 2008;8:21</RefSource>
<PMID Version="1">18570642</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Mov Disord. 2006 Feb;21(2):267-70</RefSource>
<PMID Version="1">16161144</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009315" MajorTopicYN="N">National Institute of Mental Health (U.S.)</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055825" MajorTopicYN="N">National Institute of Neurological Disorders and Stroke</DescriptorName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">HALMS486454</OtherID>
<OtherID Source="NLM">PMC2891710</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>5</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>5</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20437542</ArticleId>
<ArticleId IdType="doi">10.1002/mds.22839</ArticleId>
<ArticleId IdType="pmc">PMC2891710</ArticleId>
<ArticleId IdType="mid">HALMS486454</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A90 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000A90 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:20437542 |texte= The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:20437542" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonFranceV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |